US BROKER MOVES: LOW upgraded at Citi; GTM sees multiple downgrades

SourceNewsquawk
SectionUS Equities

UPGRADES

  • Autodesk (ADSK) Upgraded to Buy at BofA; PT USD 300
  • Bentley Systems (BSY) Upgraded to Buy at BofA; PT USD 40
  • Celanese (CE) Upgraded to Overweight at JPMorgan; PT USD 68
  • Lowe's (LOW) Upgraded to Buy at Citi; PT USD 285
  • Matador Resources (MTDR) Upgraded to Buy at Truist Secs; PT USD 67
  • Seadrill (SDRL) Upgraded to Buy at Fearnley; PT USD 58

DOWNGRADES

  • Accuray (ARAY) Downgraded to Hold at Jefferies; PT 35 cents
  • Emerald Holding (EEX) Downgraded to Neutral at Rosenblatt Securities Inc
  • Gitlab (GTLB) Downgraded to Market Perform at Raymond James
  • LENZ Therapeutics Inc (LENZ) Downgraded to Neutral at Piper Sandler; PT USD 12
  • Toast (TOST) Downgraded to Neutral at Rothschild & Co Redburn; PT USD 35
  • United Parks & Resorts (PRKS) Downgraded to Hold at Stifel; PT USD 40
  • ZoomInfo (GTM) Downgraded to Hold at Canaccord; PT USD 5
  • ZoomInfo (GTM) Downgraded to Underweight at Piper Sandler; PT USD 4
  • ZoomInfo (GTM) Downgraded to Hold at Stifel; PT USD 4

INITIATIONS

  • Aevex (AVEX) Initiated at New Outperform at William Blair
  • Aevex (AVEX) Initiated at New Outperform at Raymond James; PT USD 35
  • Aevex (AVEX) Initiated at New Buy at Jefferies; PT USD 32
  • Aevex (AVEX) Initiated at New Outperform at Baird; PT USD 38
  • Aevex (AVEX) Initiated at New Outperform at RBC; PT USD 31
  • Aevex (AVEX) Initiated at New Overweight at JPMorgan; PT USD 33
  • Aevex (AVEX) Initiated at New Buy at Goldman; PT USD 34
  • Alamar Biosciences (ALMR) Initiated at New Outperform at Leerink; PT USD 35
  • Alamar Biosciences (ALMR) Initiated at New Buy at TD Cowen; PT USD 30
  • Alamar Biosciences (ALMR) Initiated at New Overweight at JPMorgan; PT USD 30
  • Alamar Biosciences (ALMR) Initiated at New Buy at Stifel; PT USD 28
  • Annexon (ANNX) Initiated at New Neutral at Goldman; PT USD 7
  • Chesapeake Utilities (CPK) Reinstated Equal-Weight at Wells Fargo
  • Design Therapeutics (DSGN) Initiated at New Overweight at Cantor
  • Dexcom (DXCM) Initiated at New Buy at Benchmark
  • Enliven Therapeutics (ELVN) Initiated at New Buy at Guggenheim; PT USD 80
  • Forum Markets (FRMM) Initiated at New Buy at Clear Street; PT USD 11
  • H2O America (HTO) Reinstated Equal-Weight at Wells Fargo; PT USD 60
  • Insulet (PODD) Initiated at New Buy at Benchmark
  • Kailera Therapeutics (KLRA) Initiated at New Outperform at Evercore ISI
  • Kailera Therapeutics (KLRA) Initiated at New Outperform at Leerink; PT USD 36
  • Kailera Therapeutics (KLRA) Initiated at New Buy at TD Cowen; PT USD 57
  • Kailera Therapeutics (KLRA) Initiated at New Outperform at William Blair
  • Kailera Therapeutics (KLRA) Initiated at New Buy at Jefferies; PT USD 48
  • Kailera Therapeutics (KLRA) Initiated at New Overweight at JPMorgan; PT USD 30
  • Lumentum (LITE) Initiated at New Buy at CTBC Securities; PT USD 1,250
  • MaxLinear (MXL) Reinstated Buy at Benchmark; PT USD 28
  • MiniMed Group (MMED) Initiated at New Buy at Benchmark
  • New Jersey Resources (NJR) Reinstated Overweight at Wells Fargo
  • Northwest Natural (NWN) Reinstated Underweight at Wells Fargo; PT USD 50
  • ONE Gas (OGS) Reinstated Underweight at Wells Fargo; PT USD 85
  • Palvella Therapeutics (PVLA) Initiated at New Overweight at Stephens; PT USD 220
  • Southwest Gas (SWX) Reinstated Overweight at Wells Fargo; PT USD 105
  • Spire (SR) Reinstated Overweight at Wells Fargo; PT USD 96
  • Sunbelt Rentals (SUNB) Initiated at New Outperform at Bernstein; PT USD 86
  • Tandem Diabetes (TNDM) Initiated at New Hold at Benchmark
  • UGI (UGI) Reinstated Overweight at Wells Fargo; PT USD 46
  • Unitil (UTL) Initiated at New Equal-Weight at Wells Fargo; PT USD 56
  • Varonis Systems (VRNS) Initiated at New Buy at Rosenblatt Securities Inc
  • Versant Media (VSNT) Initiated at New Neutral at JPMorgan; PT USD 43
Published: Updated: